25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ARGX (Argen-X) Stock Analysis
Buy, Hold or Sell?

Let's analyze Argen-X together

I guess you are interested in Argen-X. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Argen-X’s Financial Insights
  • 📈 Technical Analysis (TA) – Argen-X’s Price Targets

I'm going to help you getting a better view of Argen-X. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Argen-X

I send you an email if I find something interesting about Argen-X.

1. Quick Overview

1.1. Quick analysis of Argen-X (30 sec.)










1.2. What can you expect buying and holding a share of Argen-X? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€62.45
Expected worth in 1 year
€140.71
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
€78.26
Return On Investment
14.2%

For what price can you sell your share?

Current Price per Share
€551.80
Expected price per share
€502.40 - €593.60
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Argen-X (5 min.)




Live pricePrice per Share (EOD)
€551.80
Intrinsic Value Per Share
€-125.99 - €-41.21
Total Value Per Share
€-63.54 - €21.23

2.2. Growth of Argen-X (5 min.)




Is Argen-X growing?

Current yearPrevious yearGrowGrow %
How rich?$4b$2.8b$1.2b31.3%

How much money is Argen-X making?

Current yearPrevious yearGrowGrow %
Making money-$295m-$709.5m$414.5m140.5%
Net Profit Margin-24.1%-172.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Argen-X (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#23 / 913

Most Revenue
#13 / 913

Most Profit
#902 / 913

Most Efficient
#405 / 913
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Argen-X?

Welcome investor! Argen-X's management wants to use your money to grow the business. In return you get a share of Argen-X.

First you should know what it really means to hold a share of Argen-X. And how you can make/lose money.

Speculation

The Price per Share of Argen-X is €551.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Argen-X.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Argen-X, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €62.45. Based on the TTM, the Book Value Change Per Share is €19.57 per quarter. Based on the YOY, the Book Value Change Per Share is €4.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Argen-X.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-4.86-0.9%-4.86-0.9%-11.68-2.1%-7.25-1.3%-3.86-0.7%
Usd Book Value Change Per Share21.133.8%21.133.8%4.600.8%11.462.1%6.691.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share21.133.8%21.133.8%4.600.8%11.462.1%6.691.2%
Usd Price Per Share370.95-370.95-376.13-300.80-169.02-
Price to Earnings Ratio-76.39--76.39--32.21--47.47--58.92-
Price-to-Total Gains Ratio17.56-17.56-81.78-34.38-23.01-
Price to Book Ratio5.50-5.50-8.12-7.85-9.85-
Price-to-Total Gains Ratio17.56-17.56-81.78-34.38-23.01-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share595.88882
Number of shares1
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share21.1311.46
Usd Total Gains Per Share21.1311.46
Gains per Quarter (1 shares)21.1311.46
Gains per Year (1 shares)84.5145.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10857504636
2016916009282
302542450138128
403383300183174
504234150229220
605075000275266
705925850321312
806766700367358
907617550413404
1008458400458450

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.013.00.00.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%11.02.00.084.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.013.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%11.02.00.084.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Argen-X compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--19.56519.5650%4.259+359%10.613+84%6.199+216%
Book Value Per Share--62.44662.4460%42.881+46%37.495+67%20.575+204%
Current Ratio--9.7499.7490%9.178+6%8.443+15%8.493+15%
Debt To Asset Ratio--0.0980.0980%0.102-4%0.169-42%0.172-43%
Debt To Equity Ratio--0.1090.1090%0.114-5%0.215-49%0.229-53%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--23403914418.00023403914418.0000%22896516262.000+2%18607913957.642+26%10458438350.635+124%
Eps---4.497-4.4970%-10.814+140%-6.713+49%-3.573-21%
Ev To Ebitda Ratio---131.441-131.4410%-42.484-68%-66.779-49%-68.486-48%
Ev To Sales Ratio--20.61020.6100%60.198-66%129.190-84%128.137-84%
Free Cash Flow Per Share---7.073-7.0730%-14.731+108%-7.580+7%-3.971-44%
Free Cash Flow To Equity Per Share--13.29813.2980%-1.873+114%7.540+76%4.717+182%
Gross Profit Margin--1.6851.6850%1.003+68%1.180+43%1.093+54%
Intrinsic Value_10Y_max---41.212--------
Intrinsic Value_10Y_min---125.991--------
Intrinsic Value_1Y_max---4.014--------
Intrinsic Value_1Y_min---11.502--------
Intrinsic Value_3Y_max---12.149--------
Intrinsic Value_3Y_min---35.737--------
Intrinsic Value_5Y_max---20.390--------
Intrinsic Value_5Y_min---61.076--------
Market Cap33527919800.000+38%20871403500.00020871403500.0000%21163056300.000-1%16924368940.000+23%9509886393.000+119%
Net Profit Margin---0.241-0.2410%-1.728+618%-3.929+1533%-2.995+1145%
Operating Margin---0.248-0.2480%-1.671+575%-3.676+1385%-2.925+1081%
Operating Ratio--1.3471.3470%2.752-51%6.447-79%6.037-78%
Pb Ratio8.836+38%5.5015.5010%8.122-32%7.850-30%9.845-44%
Pe Ratio-122.714-61%-76.391-76.3910%-32.208-58%-47.474-38%-58.920-23%
Price Per Share551.800+38%343.500343.5000%348.300-1%278.540+23%156.513+119%
Price To Free Cash Flow Ratio-78.010-61%-48.562-48.5620%-23.643-51%-9.342-81%-23.467-52%
Price To Total Gains Ratio28.203+38%17.55717.5570%81.775-79%34.377-49%23.010-24%
Quick Ratio--11.37211.3720%12.775-11%11.710-3%11.814-4%
Return On Assets---0.065-0.0650%-0.226+249%-0.167+156%-0.174+167%
Return On Equity---0.072-0.0720%-0.252+250%-0.206+186%-0.219+204%
Total Gains Per Share--19.56519.5650%4.259+359%10.613+84%6.199+216%
Usd Book Value--4097455371.4124097455371.4120%2813664547.380+46%2460275278.341+67%1350033957.270+204%
Usd Book Value Change Per Share--21.12921.1290%4.600+359%11.461+84%6.694+216%
Usd Book Value Per Share--67.43667.4360%46.307+46%40.491+67%22.219+204%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--25273887179.99825273887179.9980%24725947911.334+2%20094686282.858+26%11294067574.850+124%
Usd Eps---4.856-4.8560%-11.678+140%-7.250+49%-3.858-21%
Usd Free Cash Flow---464133151.849-464133151.8490%-966617820.462+108%-497396661.323+7%-260559541.202-44%
Usd Free Cash Flow Per Share---7.639-7.6390%-15.909+108%-8.186+7%-4.288-44%
Usd Free Cash Flow To Equity Per Share--14.36114.3610%-2.022+114%8.142+76%5.094+182%
Usd Market Cap36206800592.020+38%22539028639.65022539028639.6500%22853984498.370-1%18276626018.306+23%10269726315.801+119%
Usd Price Per Share595.889+38%370.946370.9460%376.129-1%300.795+23%169.018+119%
Usd Profit---295049282.332-295049282.3320%-709585059.116+140%-449308789.438+52%-240831994.379-18%
Usd Revenue--1226300548.4181226300548.4180%410740824.600+199%451454963.596+172%235318247.185+421%
Usd Total Gains Per Share--21.12921.1290%4.600+359%11.461+84%6.694+216%
 EOD+6 -2MRQTTM+0 -0YOY+31 -75Y+33 -510Y+27 -11

3.3 Fundamental Score

Let's check the fundamental score of Argen-X based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-122.714
Price to Book Ratio (EOD)Between0-18.836
Net Profit Margin (MRQ)Greater than0-0.241
Operating Margin (MRQ)Greater than0-0.248
Quick Ratio (MRQ)Greater than111.372
Current Ratio (MRQ)Greater than19.749
Debt to Asset Ratio (MRQ)Less than10.098
Debt to Equity Ratio (MRQ)Less than10.109
Return on Equity (MRQ)Greater than0.15-0.072
Return on Assets (MRQ)Greater than0.05-0.065
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Argen-X based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.945
Ma 20Greater thanMa 50562.360
Ma 50Greater thanMa 100598.988
Ma 100Greater thanMa 200594.934
OpenGreater thanClose543.000
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Argen-X

argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, thyroid eye disease, bullous pemphigoid, myositis, primary sjögren's syndrome, post-covid postural orthostatic tachycardia syndrome, membranous nephropathy, lupus nephropathy, anca-associated vasculitis, and antibody mediated rejection; ENHANZE SC; Empasiprubart for multifocal motor neuropath, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome and amyotrophic lateral sclerosis. The company is developing ARGX-213 targets FcRn; ARGX-121 and ARGX-220 targets immune system; ARGX-109 targets IL-6; ARGX-118 for inflammation; and ARGX-109, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It owns VYVGART; VYVGART HYTRULO; VYVDURA; ARGENX; ABDEG; NHANCE; SIMPLE ANTIBODY; and ARGENXMEDHUB. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., and Shire International GmbH. It has collaboration agreement with Genmab A/S to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology, as well as a strategic collaboration with IQVIA Holdings Inc. to provide safety systems and services. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.

Fundamental data was last updated by Penke on 2025-03-19 04:11:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Argen-X earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Argen-X to the Biotechnology industry mean.
  • A Net Profit Margin of -24.1% means that €-0.24 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Argen-X:

  • The MRQ is -24.1%. The company is making a huge loss. -2
  • The TTM is -24.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-24.1%TTM-24.1%0.0%
TTM-24.1%YOY-172.8%+148.7%
TTM-24.1%5Y-392.9%+368.8%
5Y-392.9%10Y-299.5%-93.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.1%-88.1%+64.0%
TTM-24.1%-190.6%+166.5%
YOY-172.8%-199.6%+26.8%
5Y-392.9%-336.0%-56.9%
10Y-299.5%-488.5%+189.0%
4.3.1.2. Return on Assets

Shows how efficient Argen-X is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Argen-X to the Biotechnology industry mean.
  • -6.5% Return on Assets means that Argen-X generated €-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Argen-X:

  • The MRQ is -6.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.5%TTM-6.5%0.0%
TTM-6.5%YOY-22.6%+16.1%
TTM-6.5%5Y-16.7%+10.2%
5Y-16.7%10Y-17.4%+0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.5%-11.9%+5.4%
TTM-6.5%-11.9%+5.4%
YOY-22.6%-11.6%-11.0%
5Y-16.7%-12.7%-4.0%
10Y-17.4%-14.3%-3.1%
4.3.1.3. Return on Equity

Shows how efficient Argen-X is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Argen-X to the Biotechnology industry mean.
  • -7.2% Return on Equity means Argen-X generated €-0.07 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Argen-X:

  • The MRQ is -7.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.2%TTM-7.2%0.0%
TTM-7.2%YOY-25.2%+18.0%
TTM-7.2%5Y-20.6%+13.4%
5Y-20.6%10Y-21.9%+1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.2%-15.6%+8.4%
TTM-7.2%-15.8%+8.6%
YOY-25.2%-14.6%-10.6%
5Y-20.6%-18.0%-2.6%
10Y-21.9%-19.2%-2.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Argen-X.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Argen-X is operating .

  • Measures how much profit Argen-X makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Argen-X to the Biotechnology industry mean.
  • An Operating Margin of -24.8% means the company generated €-0.25  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Argen-X:

  • The MRQ is -24.8%. The company is operating very inefficient. -2
  • The TTM is -24.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-24.8%TTM-24.8%0.0%
TTM-24.8%YOY-167.1%+142.3%
TTM-24.8%5Y-367.6%+342.8%
5Y-367.6%10Y-292.5%-75.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.8%-193.7%+168.9%
TTM-24.8%-296.4%+271.6%
YOY-167.1%-206.9%+39.8%
5Y-367.6%-367.9%+0.3%
10Y-292.5%-475.9%+183.4%
4.3.2.2. Operating Ratio

Measures how efficient Argen-X is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.35 means that the operating costs are €1.35 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Argen-X:

  • The MRQ is 1.347. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.347. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.347TTM1.3470.000
TTM1.347YOY2.752-1.405
TTM1.3475Y6.447-5.100
5Y6.44710Y6.037+0.409
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3472.025-0.678
TTM1.3473.215-1.868
YOY2.7522.982-0.230
5Y6.4474.689+1.758
10Y6.0376.513-0.476
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Argen-X.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Argen-X is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.75 means the company has €9.75 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Argen-X:

  • The MRQ is 9.749. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.749. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.749TTM9.7490.000
TTM9.749YOY9.178+0.571
TTM9.7495Y8.443+1.306
5Y8.44310Y8.493-0.050
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.7493.616+6.133
TTM9.7493.879+5.870
YOY9.1784.483+4.695
5Y8.4435.950+2.493
10Y8.4936.240+2.253
4.4.3.2. Quick Ratio

Measures if Argen-X is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Argen-X to the Biotechnology industry mean.
  • A Quick Ratio of 11.37 means the company can pay off €11.37 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Argen-X:

  • The MRQ is 11.372. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 11.372. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.372TTM11.3720.000
TTM11.372YOY12.775-1.404
TTM11.3725Y11.710-0.338
5Y11.71010Y11.814-0.104
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.3722.966+8.406
TTM11.3723.336+8.036
YOY12.7754.252+8.523
5Y11.7105.921+5.789
10Y11.8146.474+5.340
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Argen-X.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Argen-X assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Argen-X to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.10 means that Argen-X assets are financed with 9.8% credit (debt) and the remaining percentage (100% - 9.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Argen-X:

  • The MRQ is 0.098. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.098. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.098TTM0.0980.000
TTM0.098YOY0.102-0.004
TTM0.0985Y0.169-0.071
5Y0.16910Y0.172-0.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0980.340-0.242
TTM0.0980.340-0.242
YOY0.1020.312-0.210
5Y0.1690.359-0.190
10Y0.1720.382-0.210
4.5.4.2. Debt to Equity Ratio

Measures if Argen-X is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Argen-X to the Biotechnology industry mean.
  • A Debt to Equity ratio of 10.9% means that company has €0.11 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Argen-X:

  • The MRQ is 0.109. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.109. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.109TTM0.1090.000
TTM0.109YOY0.114-0.005
TTM0.1095Y0.215-0.106
5Y0.21510Y0.229-0.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1090.393-0.284
TTM0.1090.428-0.319
YOY0.1140.395-0.281
5Y0.2150.451-0.236
10Y0.2290.493-0.264
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Argen-X generates.

  • Above 15 is considered overpriced but always compare Argen-X to the Biotechnology industry mean.
  • A PE ratio of -76.39 means the investor is paying €-76.39 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Argen-X:

  • The EOD is -122.714. Based on the earnings, the company is expensive. -2
  • The MRQ is -76.391. Based on the earnings, the company is expensive. -2
  • The TTM is -76.391. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-122.714MRQ-76.391-46.324
MRQ-76.391TTM-76.3910.000
TTM-76.391YOY-32.208-44.183
TTM-76.3915Y-47.474-28.917
5Y-47.47410Y-58.920+11.446
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-122.714-2.074-120.640
MRQ-76.391-2.522-73.869
TTM-76.391-3.216-73.175
YOY-32.208-3.300-28.908
5Y-47.474-6.225-41.249
10Y-58.920-6.955-51.965
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Argen-X:

  • The EOD is -78.010. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -48.562. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -48.562. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-78.010MRQ-48.562-29.448
MRQ-48.562TTM-48.5620.000
TTM-48.562YOY-23.643-24.918
TTM-48.5625Y-9.342-39.220
5Y-9.34210Y-23.467+14.125
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-78.010-2.854-75.156
MRQ-48.562-3.511-45.051
TTM-48.562-3.835-44.727
YOY-23.643-4.297-19.346
5Y-9.342-8.217-1.125
10Y-23.467-9.311-14.156
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Argen-X is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.50 means the investor is paying €5.50 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Argen-X:

  • The EOD is 8.836. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.501. Based on the equity, the company is overpriced. -1
  • The TTM is 5.501. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD8.836MRQ5.501+3.336
MRQ5.501TTM5.5010.000
TTM5.501YOY8.122-2.622
TTM5.5015Y7.850-2.349
5Y7.85010Y9.845-1.995
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD8.8361.874+6.962
MRQ5.5012.120+3.381
TTM5.5012.372+3.129
YOY8.1222.453+5.669
5Y7.8503.811+4.039
10Y9.8454.584+5.261
4.6.2. Total Gains per Share

2.4. Latest News of Argen-X

Does Argen-X still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Argen-X to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-02-28
17:04
Argenx's Q4 Sales Backed by Vyvgart's Growth, Oppenheimer SaysRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Other Assets  034,42234,42227,25561,67757,266118,943-480,699-361,757



6.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets4,542,458
Total Liabilities444,951
Total Stockholder Equity4,097,507
 As reported
Total Liabilities 444,951
Total Stockholder Equity+ 4,097,507
Total Assets = 4,542,458

Assets

Total Assets4,542,458
Total Current Assets4,123,737
Long-term Assets418,721
Total Current Assets
Cash And Cash Equivalents 2,048,844
Short-term Investments 1,131,000
Net Receivables 499,271
Inventory 310,550
Other Current Assets 134,072
Total Current Assets  (as reported)4,123,737
Total Current Assets  (calculated)4,123,737
+/-0
Long-term Assets
Property Plant Equipment 22,675
Long Term Investments 47,155
Intangible Assets 125,228
Long-term Assets Other 126,452
Long-term Assets  (as reported)418,721
Long-term Assets  (calculated)321,510
+/- 97,211

Liabilities & Shareholders' Equity

Total Current Liabilities422,993
Long-term Liabilities21,958
Total Stockholder Equity4,097,507
Total Current Liabilities
Short-term Debt 4,646
Accounts payable 245,557
Other Current Liabilities 168,456
Total Current Liabilities  (as reported)422,993
Total Current Liabilities  (calculated)418,659
+/- 4,334
Long-term Liabilities
Capital Lease Obligations 20,000
Long-term Liabilities  (as reported)21,958
Long-term Liabilities  (calculated)20,000
+/- 1,958
Total Stockholder Equity
Common Stock7,058
Retained Earnings -2,404,844
Accumulated Other Comprehensive Income 72,071
Other Stockholders Equity 6,423,222
Total Stockholder Equity (as reported)4,097,507
Total Stockholder Equity (calculated)4,097,507
+/-0
Other
Capital Stock7,058
Cash and Short Term Investments 3,179,844
Common Stock Shares Outstanding 57,169
Current Deferred Revenue3,923
Liabilities and Stockholders Equity 4,542,458
Net Debt -2,028,844
Net Invested Capital 4,097,507
Net Working Capital 3,700,744
Property Plant and Equipment Gross 45,351
Short Long Term Debt Total 20,000



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
> Total Assets 
12,259
31,936
22,943
34,554
71,335
50,324
111,189
446,066
661,470
1,604,500
2,287,279
2,850,274
3,134,261
4,542,458
4,542,4583,134,2612,850,2742,287,2791,604,500661,470446,066111,18950,32471,33534,55422,94331,93612,259
   > Total Current Assets 
11,890
31,564
22,491
33,745
69,954
48,326
107,006
441,130
654,592
1,537,201
2,063,953
2,542,971
2,774,197
4,123,737
4,123,7372,774,1972,542,9712,063,9531,537,201654,592441,130107,00648,32669,95433,74522,49131,56411,890
       Cash And Cash Equivalents 
10,499
30,511
20,418
31,387
39,234
38,884
94,501
229,543
321,371
370,842
1,220,916
1,334,676
800,740
2,048,844
2,048,844800,7401,334,6761,220,916370,842321,371229,54394,50138,88439,23431,38720,41830,51110,499
       Short-term Investments 
0
0
1,389
691
29,008
7,460
7,181
203,133
324,217
1,124,495
782,284
1,002,052
1,391,808
1,131,000
1,131,0001,391,8081,002,052782,2841,124,495324,217203,1337,1817,46029,0086911,38900
       Net Receivables 
1,385
986
569
1,520
793
1,485
2,242
3,608
3,644
22,599
235
32,707
277,275
499,271
499,271277,27532,70723522,5993,6443,6082,2421,4857931,5205699861,385
       Inventory 
0
66
112
146
112
0
0
0
0
-1,022,312
25,280
109,076
228,353
310,550
310,550228,353109,07625,280-1,022,3120000112146112660
   > Long-term Assets 
369
372
451
810
1,383
1,998
4,183
4,936
6,878
67,299
223,326
307,303
360,064
418,721
418,721360,064307,303223,32667,2996,8784,9364,1831,9981,383810451372369
       Property Plant Equipment 
328
356
232
166
202
272
805
813
942
9,142
11,689
15,843
16,235
22,675
22,67516,23515,84311,6899,142942813805272202166232356328
       Long Term Investments 
0
0
0
1
1
1
1
1
1
2,596
5,140
53,169
40,481
47,155
47,15540,48153,1695,1402,596111111000
       Intangible Assets 
41
16
0
0
9
8
18
16
64
44,957
167,954
171,684
174,901
125,228
125,228174,901171,684167,95444,95764161889001641
       Long-term Assets Other 
0
0
218
642
1,170
1,718
1,208
458
287
705
22,265
34,416
49,225
126,452
126,45249,22534,41622,2657052874581,2081,7181,17064221800
> Total Liabilities 
2,028
4,042
6,281
4,570
10,275
9,508
44,569
31,241
45,812
428,280
607,399
316,050
320,561
444,951
444,951320,561316,050607,399428,28045,81231,24144,5699,50810,2754,5706,2814,0422,028
   > Total Current Liabilities 
2,028
4,042
6,281
4,571
10,275
9,508
44,568
31,211
45,804
179,058
329,604
301,239
302,277
422,993
422,993302,277301,239329,604179,05845,80431,21144,5689,50810,2754,5716,2814,0422,028
       Short-term Debt 
0
2,193
2,238
0
0
0
0
0
0
2,218
3,476
3,509
3,417
4,646
4,6463,4173,5093,4762,2180000002,2382,1930
       Accounts payable 
1,689
363
1,851
1,242
2,010
4,974
4,610
5,286
27,618
65,595
206,542
208,850
188,721
245,557
245,557188,721208,850206,54265,59527,6185,2864,6104,9742,0101,2421,8513631,689
       Other Current Liabilities 
0
3,679
3,858
2,698
4,046
4,525
8,211
6,448
11,499
91,972
68,710
84,565
106,958
168,456
168,456106,95884,56568,71091,97211,4996,4488,2114,5254,0462,6983,8583,6790
   > Long-term Liabilities 
2,028
2,556
4,661
-1
6,218
6,599
1
30
8
249,222
277,795
14,811
18,284
21,958
21,95818,28414,811277,795249,22283016,5996,218-14,6612,5562,028
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
4,540
0
0
0
0
00004,540000000000
       Other Liabilities 
0
0
0
0
0
0
10,071
1,460
7
245,009
270,682
6,855
9,276
0
09,2766,855270,682245,00971,46010,071000000
> Total Stockholder Equity
10,231
27,894
16,661
29,984
61,060
40,816
66,619
414,825
615,658
1,176,220
1,679,880
2,534,224
2,813,700
4,097,507
4,097,5072,813,7002,534,2241,679,8801,176,220615,658414,82566,61940,81661,06029,98416,66127,89410,231
   Common Stock
248
439
449
644
1,915
1,730
2,115
3,869
4,113
4,787
5,857
6,233
6,640
7,058
7,0586,6406,2335,8574,7874,1133,8692,1151,7301,915644449439248
   Retained Earnings -2,404,844-2,109,791-1,400,197-1,060,708-372,281-193,942-120,946-76,204-55,969-43,655-35,215-25,618-12,521-8,408
   Accumulated Other Comprehensive Income 
297
540
1,563
1,970
2,898
5,088
7,880
14,148
35,388
78,918
200,674
465,413
606,971
72,071
72,071606,971465,413200,67478,91835,38814,1487,8805,0882,8981,9701,563540297
   Capital Surplus 
0
0
0
0
0
82,169
126,358
430,518
673,454
1,308,539
0
0
0
0
00001,308,539673,454430,518126,35882,16900000
   Treasury Stock00000000000000
   Other Stockholders Equity 
18,097
39,441
41,917
63,281
100,495
90,417
133,382
465,458
732,418
1,558,641
2,728,309
3,462,775
4,309,880
6,423,222
6,423,2224,309,8803,462,7752,728,3091,558,641732,418465,458133,38290,417100,49563,28141,91739,44118,097



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,226,316
Cost of Revenue-117,835
Gross Profit1,108,4811,108,481
 
Operating Income (+$)
Gross Profit1,108,481
Operating Expense-1,533,530
Operating Income-425,049-425,049
 
Operating Expense (+$)
Research Development755,114
Selling General Administrative507,393
Selling And Marketing Expenses202,146
Operating Expense1,533,5301,464,653
 
Net Interest Income (+$)
Interest Income78,079
Interest Expense-904
Other Finance Cost-1,001
Net Interest Income78,176
 
Pretax Income (+$)
Operating Income-425,049
Net Interest Income78,176
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-304,496-545,602
EBIT - interestExpense = -304,496
-304,496
-294,149
Interest Expense904
Earnings Before Interest and Taxes (EBIT)-303,592-303,592
Earnings Before Interest and Taxes (EBITDA)-192,285
 
After tax Income (+$)
Income Before Tax-304,496
Tax Provision--50,061
Net Income From Continuing Ops-234,497-254,435
Net Income-295,053
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,651,365
Total Other Income/Expenses Net120,553-78,176
 

Technical Analysis of Argen-X
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Argen-X. The general trend of Argen-X is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Argen-X's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Argen-X Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Argen-X.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 575.80 < 577.40 < 593.60.

The bearish price targets are: 516.20 > 507.40 > 502.40.

Know someone who trades $ARGX? Share this with them.👇

Argen-X Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Argen-X. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Argen-X Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Argen-X. The current macd is -12.28516926.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Argen-X price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Argen-X. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Argen-X price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Argen-X Daily Moving Average Convergence/Divergence (MACD) ChartArgen-X Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Argen-X. The current adx is 19.56.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Argen-X shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Argen-X Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Argen-X. The current sar is 575.80.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Argen-X Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Argen-X. The current rsi is 39.94. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Argen-X Daily Relative Strength Index (RSI) ChartArgen-X Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Argen-X. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Argen-X price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Argen-X Daily Stochastic Oscillator ChartArgen-X Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Argen-X. The current cci is -56.26274424.

Argen-X Daily Commodity Channel Index (CCI) ChartArgen-X Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Argen-X. The current cmo is -19.17389611.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Argen-X Daily Chande Momentum Oscillator (CMO) ChartArgen-X Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Argen-X. The current willr is -40.26845638.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Argen-X is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Argen-X Daily Williams %R ChartArgen-X Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Argen-X.

Argen-X Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Argen-X. The current atr is 16.05.

Argen-X Daily Average True Range (ATR) ChartArgen-X Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Argen-X. The current obv is 1,597,485.

Argen-X Daily On-Balance Volume (OBV) ChartArgen-X Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Argen-X. The current mfi is 35.23.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Argen-X Daily Money Flow Index (MFI) ChartArgen-X Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Argen-X.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-10MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-01-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-01-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Argen-X Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Argen-X based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.945
Ma 20Greater thanMa 50562.360
Ma 50Greater thanMa 100598.988
Ma 100Greater thanMa 200594.934
OpenGreater thanClose543.000
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Argen-X with someone you think should read this too:
  • Are you bullish or bearish on Argen-X? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Argen-X? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Argen-X

I send you an email if I find something interesting about Argen-X.


Comments

How you think about this?

Leave a comment

Stay informed about Argen-X.

Receive notifications about Argen-X in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.